Sponsor the 2020 Policy Summit


Thank You to Our Current Sponsors

 

Sponsorship Information

ASGCT works tirelessly to advocate for policies that support the work of our members and the field as a whole with governmental entities, including Congress, FDA, CMS, and NIH. The Society influences policymakers on ways to support innovative research, expeditious development, and patient access to gene and cell therapy from the unique perspective of a professional membership association.

The Society provides educational programming that connects policy and industry thought leaders with corporate, government relations, market access, regulatory, and scientific professionals. In 2019, we hosted nearly 400 attendees in an expanded, multi-day Policy Summit in Washington, D.C. addressing payment policy, and global regulatory and ethical issues.

By sponsoring the 2020 Policy Summit, you are empowering ASGCT’s year-round advocacy efforts. Listed below are just a few initiatives your funding will support in 2020 and beyond.

  • Advocacy of coverage, reimbursement, and new payment models for gene therapies
  • Recommendations for streamlined regulation of safe and effective products
  • Promotion of newborn screening policies that facilitate early diagnosis and treatment
  • Support for robust NIH and FDA funding levels
  • Education of Hill members and staff on gene therapy and relevant policy issues

Learn more about ASGCT advocacy efforts in 2019 and 2020 priorities.

Contact Laura Otto, Director of Engagement, to learn more about sponsorship opportunities. The deadline to support the Policy Summit is September 9, 2020. 

2020

ASGCT Policy Summit

September 23-25, 2020